Avoid repeated freeze-thaw cycles, which can degrade peptide integrity
Both semaglutide (Ozempic, Wegovy) and tirzepatide (Zepbound) are designed for once-weekly dosing and that long-acting design means they don't leave your body quickly either
doi: 10.1186/1479-5868-9-78 Summary Keywords type 2 diabetes, exercise-as-a-medicine, training, metabolism, health Citation Codella R, Senesi P and Luzi L (2025) GLP-1 agonists and exercise: the future of lifestyle prioritization
Common indicators include: Elevated homocysteine levels (above 10-15 mol/L) Chronic fatigue and low energy Anxiety, depression, or brain fog Hormonal imbalances (PMS, infertility, irregular periods) Recurrent miscarriages or pregnancy complications Cardiovascular issues (high blood pressure, blood clots) Digestive problems (IBS, bloating, food sensitivities) Chronic inflammation or autoimmune conditions Many people discover they have an MTHFR mutation after experiencing unexplained health issues or through genetic testing ordered by their healthcare provider
STEP 1 Trial Weight Loss with Semaglutide In the STEP 1 trial, published in the New England Journal of Medicine, people taking semaglutide lost about 15% of their original body weight
Link Fedurco, M., et al